Login

GW PHARMACEUTICALS PLC SEC Filings

Filed On Filing
11 Feb 2022 SEC SCHEDULE 13G
17 May 2021 15-12B
07 May 2021 Form 4: Tovey Christopher J., Chief Operating Officer

Returned 2,496 shares to the issuer · Disposed of 723,852 Share Options (Disposition to Issuer)

07 May 2021 Form 4: Cline Darren S, U.S. Chief Commercial Officer

Returned 5,556 shares to the issuer · Disposed of 579,720 Share Options (Disposition to Issuer)

07 May 2021 Form 4: Gryska David W, Director

Disposed of 57,672 Share Options (Disposition to Issuer)

07 May 2021 Form 4: Snyder Douglas B., Chief Legal Officer

Returned 61,848 shares to the issuer · Disposed of 671,136 Share Options (Disposition to Issuer)

07 May 2021 Form 4: Gover Justin D., Director

Returned 2,546,129 shares to the issuer · Disposed of 2,293,596 Share Options (Disposition to Issuer)

07 May 2021 Form 4: Noble James, Director

Returned 27,492 shares to the issuer · Disposed of 139,080 Share Options (Disposition to Issuer)

07 May 2021 Form 4: Mackey Catherine J, Director

Returned 10,536 shares to the issuer · Disposed of 111,912 Share Options (Disposition to Issuer)

07 May 2021 Form 4: Knappertz Volker, Chief Medical Officer

Returned 92,412 shares to the issuer · Disposed of 752,484 Share Options (Disposition to Issuer)

07 May 2021 Form 4: Guy Geoffrey W Dr, Director

Returned 4,910,446 shares to the issuer · Disposed of 1,349,532 Share Options (Disposition to Issuer)

07 May 2021 Form 4: Secor Alicia, Director

Returned 10,584 shares to the issuer · Disposed of 111,912 Share Options (Disposition to Issuer)

07 May 2021 Form 4: Giacobello Scott M., Chief Financial Officer

Returned 165,108 shares to the issuer · Disposed of 640,440 Share Options (Disposition to Issuer)

07 May 2021 Form 4: Brown Cabot, Director

Returned 7,200 shares to the issuer · Disposed of 156,108 Share Options (Disposition to Issuer)

07 May 2021 Form 4: Waldegrave William A., Director

Disposed of 125,364 Share Options (Disposition to Issuer)

05 May 2021 8-K: Completion of Acquisition or Disposition of Assets; Notice of Delisting or Failure to Satisfy a Listing Rule +4 more
05 May 2021 S-8 POS
05 May 2021 S-8 POS
05 May 2021 S-8 POS
05 May 2021 POSASR

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support